MAVIRET Quality Use of Medicines - On Demand

  • $0.00 incl. GST for PSNZ members
  • $0.00 incl. GST for non-members

About the product

Go to Registration page

If you are interested in participating in the AbbVie Care Pharmacy Programme to supply MAVIRET® for hepatitis C, go to to register (the username and password are both GT1-6).

If your pharmacy is already registered and participating in the AbbVie Care Pharmacy Programme, enrol and complete the MAVIRET® Quality Use of Medicines course to supply and advise on this medicine.

MAVIRET® has an alternative XPHARM distribution arrangement. Under this XPHARM arrangement, the pharmacy does NOT purchase the medicine and cannot claim a dispensing fee in relation to MAVIRET®. The pharmacy will receive a service fee.

Sponsored by

Learning Objectives

On completion of this course, participants will be able to:

  • Review Hepatitis C infection, and the consequences if left untreated
  • Identify risk factors for infection and screening protocols in HCV patients in New Zealand
  • Describe the following for MAVIRET:
    • Recommended dosing regimen for different genotypes
    • Safety profile and common adverse events
    • Contraindications, warnings & precautions
    • Use in pregnancy and breastfeeding
    • Mechanism and management of drug-drug interactions
  • Explain how and where to report any adverse event

About this training course;

This learning consists of a presentation handout, supplementary resources and 2 multichoice assessments. A grade of 100% is needed to pass this training course.

This learning activity has been accredited by PSNZ Education (Professional Development and Training) for 2 hours of professional learning and is suitable for inclusion in a pharmacist’s records for Continuing Professional Development (CPD) purposes.

This learning can be used for your annual recertification requirements.

Register now